Neutral sphingomyelinase (NSMase) has been proposed to mediate interleukin (IL)-1β signaling in liver. In this paper, we used adenovirus-mediated gene transfer to inducibly express FLAGtagged mouse NSMase-2 in primary rat hepatocytes in order to further elucidate the molecular nature of the NSMase involved. Initial studies confirmed that the EST clone used in these experiments encoded a Mg 2+ -dependent NSMase. The in vitro activity of the heterologously expressed enzyme was inhibited in the presence of 0.5% Triton or 50 mM EDTA. In addition, the expression of this NSMase-2 clone in primary hepatocytes led to increased cellular levels of ceramide, indicating that the enzyme is active in situ. Immunofluorescence studies in Hep G2 cells infected with NSMase-2 expressing adenoviruses showed that the FLAG-tagged NSMase-2 was localized to the plasma membrane. Cell viability remained unchanged 72 h following infection and induction. The effect of NSMase-2 expression on IL-1β-induced activation of cJun N-terminal kinase (JNK) was tested. Expression of NSMase-2 increased JNK phosphorylation between 1.5-and 2-fold over the basal level. Furthermore, NSMase-2 was found to strongly increase the ability of IL-1β to phosphorylate JNK. This potentiation was mediated by a phosphatase from the PP2A family, possibly by modulating the phosphorylation pattern of IL-1β receptor-associated kinase (IRAK). In conclusion, the data presented suggest that NSMase-2 could be involved in IL-1β-induced JNK activation in hepatocytes.
Based on biochemical characterization, three major forms of SMase that can catalyze the regulated generation of ceramide have been identified. The most prominent form of SMase is plasma membrane-bound and Mg
2+
-dependent and has optimal activity at neutral pH (4) . Another seemingly different form, whose activity is also optimal at neutral pH but is Mg 2+ -independent, has been characterized in the cytosol (5) . The third form, a cation-independent acidic SMase, has been described in the endosomal/lysosomal compartment (6) . These three enzymes are considered the main pathways for ceramide generation during signal transduction (1) . However, the elucidation of their causative role in mediating cellular responses has become a difficult task, in part because of the finding that the various forms of SMase give rise to different pools of ceramide that respectively can transmit different signals. These observations have emphasized the necessity to purify and clone each SMase form.
The human and murine acid SMase has been cloned (7) . It has been found that acid SMase mediates irradiation-induced endothelial cell death (8) as well as CD28-mediated T cell maturation (9) . The neutral SMase (NSMase) activity, however, is a product of a different gene(s) as indicated by the fact that cells from Niemann-Pick patients that lack acid SMase activity (10) and acid SMase knockout mice (11) have been found to have normal NSMase activity. Based on homology searches with bacterial SMase, Stoffel and colleagues recently identified and described two putative NSMases: NSMase-1 (12) and NSMase-2 (13) . The recombinant NSMase-1, however, has been found to efficiently hydrolyze phosphatidylcholine and lyso-platelet-activating factor in addition to SM (14) and to be localized in the endoplasmic reticulum (15) . Furthermore, when overexpressed, NSMase-1 did not increase the cellular levels of ceramide and did not affect tumor necrosis factor (TNF)-α signaling (12) . Finally, NSMase-1 knockout mice appeared to have normal phenotype (16) , but their response to inflammatory challenges, such as bacterial lipopolysaccharide, was not studied.
These findings suggested that NSMase-1 might not have an active role in signaling. In contrast, NSMase-2 specifically catalyzes the hydrolysis of sphingomyelin and is activated by phosphatidylserine, both of which are characteristics for the mammalian plasma membrane SMase (17) . Furthermore, the biological function of NSMase-2 was indicated by findings that overexpression of NSMase-2 induced a significant decrease in growth in MCF-7 cells (17) . Similarly, the rat cca1, a protein identified in a screen for genes involved in contact inhibition of rat 3Y1 fibroblasts (18) , was identified later as NSMase-2 (13), suggesting that NSMase-2 may play a role in cell growth arrest. However, NSMase-2 was reported to be localized in the Golgi apparatus (13) , which puts its role in receptor signaling under question.
We have previously shown that interleukin (IL)-1β transiently activates SM hydrolysis in hepatocytes (19) . In vitro assays have also indicated that IL-1β treatment activates only the neutral SMase and not the acidic one (19) . Activation of NSMase appears to be a critical point in IL-1β signaling, leading either to the generation of ceramide or, in the presence of ceramidase activity, to the accumulation of sphingosine and sphingosine phosphate. While the accumulation of ceramide in hepatocytes mediates IL-1β-induced up-regulation of acute-phase protein expression, that of sphingosine and sphingosine phosphate affects a different set of downstream targets, including P4502C11 (19) . Activation of NSMase by IL-1β has been observed not only in hepatocytes but also in other cell types, such as mesangial cells (20) and EL-4 cells, where it is related to the regulation of IL-2 secretion (21) . Taken together, these observations seem to be indicative of NSMase involvement in the IL-1β signaling cascade.
The goal of this study was to see whether NSMase-2 plays a role in the IL-1β signaling in hepatocytes. Recombinant adenoviruses were generated, carrying the FLAG-tagged mouse NSMase-2 under a tetracycline inducible promoter, and used to infect hepatocytes. This resulted in the expression of functionally active NSMase-2 and increased accumulation of ceramide. Indirect immunofluorescence studies showed that the NSMase-2 protein was localized mainly in the plasma membrane. Finally, the overexpression of NSMase-2 strongly enhanced the ability of IL-1β to activate JNK. The mechanism for these effects of NSMAse-2 is likely to involve activation of protein phosphatase 2A (PP2A) and alterations of the phosphorylation pattern of IL-1β receptor-associated kinase (IRAK)-1, a key molecule that mediates IL-1β signaling. These results are the first to show that NSMase-2 participates in IL-1β signaling.
MATERIALS AND METHODS

Materials
Male, Fisher 344 rats (150-200 g) were purchased from Harlan (Indianapolis, IN). Waymouth's medium, MB 752/1, Dulbecco's modified Eagle's medium (DMEM), and murine recombinant IL-1β were from Life Technologies (Grand Island, NY). Matrigel was purchased from BD Bioscience Discovery Labware (Bedford, MA). C 20 sphinganine was from Matreya (Pleasant Gap, PA). N-acetyl-C 20 sphinganine was prepared by acylation of C 20 sphinganine with acetic anhydride (22) . The 6-N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino (NBD)-ceramide (NBD-Cer) and NBD-sphingomyelin (NBD-SM) were from Molecular Probes (Eugene, OR). Fetal bovine serum (FBS) was from Atlanta Biological (Atlanta, GA), and the Tet-system-approved FBS was from BD Bioscience Clontech (Palo Alto, CA). AG126 and okadaic acid (OA) were from BIOMOL Research Laboratory. (Plymouth Meeting, PA). Polyclonal anti-active JNK antibody was from Promega (Madison, WI). Polyclonal rabbit antibody specific for IRAK-1 was from Santa Cruz Biotechnology (Santa Cruz, CA). Lambda protein phosphatase (PPase) was from New England Biolabs (Beverly, MA). All the other reagents were from Sigma (St. Louis, MO).
Cloning of NSMase-2
The FLAG plasmid, adenoviral plasmid, and shuttle vector used were kindly provided by Dr. G. Smith (University of Kentucky). Recombinant adenoviruses were constructed as described by He at al. (23). In brief, full-length mouse NSMase-2 (from the start codon up to, but not including, the stop codon) was PCR amplified from the mouse I.M.A.G.E. consortium clone (ID#2076661), using primers incorporating unique restriction sites, and confirmed by sequencing. The NSMase-2 was then tagged at the carboxy terminus by directional cloning of the gene into pBluescript-FLAG. The tagged gene was then excised and cloned directionally into a shuttle vector pAd.trac.teton upstream of PolyA sequence and under the control of TRE (tetracycline response element) creating pAd.trac.teton-NSMase-2. The shuttle vector also encodes the "Tet-On" gene and the CMV promoter, allowing induction of our target gene in the presence of doxycycline.
Inducible expression of the cloned NSMase-2 was verified by transfecting HEK293 cells with pAd.trac.teton-NSMase-2 using lipofectamine plus reagent (Life Technologies), treating with doxycycline (2 µg/ml), harvesting the cells after 16-32 h, and performing a Western blot on the sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)-separated cell extracts using anti-FLAG antibody. After confirming the inducible expression of a functional SMase, we then linearized the construct with PacI and cotransformed it into Escherichia coli strain BJ5183 with an adenoviral backbone plasmid (pAdEasy-1) (23). Recombinants were selected for kanamycin resistance, and recombination was confirmed by multiple restriction endonuclease analyses. Finally, the linearized recombinant plasmid was transfected into adenovirus packing cell line, 293 cells. Recombinant adenoviruses, AdNSMase-2, were generated within 12 days.
Cells were collected and lysed, and the viral lysate was used to infect fresh 293 cells. This amplification process was repeated twice, and the resulting adenovirus was purified using the Virakit Adeno4 kit (Virapur, Carlsbad, CA). The total number of viral particles was determined by OD 260 measurement, and the infectious titer was determined using the BD Adeno-X Rapid Titer Kit (BD Bioscience Clontech). Each batch was titrated to establish the multiplicity of infection (MOI) and doxycycline concentration that produce optimal NSMase activity and no adenovirus-associated cytotoxicity. Routinely, cells were infected at a MOI between 2 and 5.
Cell culture
The tissue culture dishes were coated with Matrigel (6.3 mg/ml) as described previously (2) . Hepatocytes were isolated from ether-anesthetized rats by in situ collagenase perfusion, and the cells were plated (3.5×10 6 per plate; viability >80%) in 3 ml of Waymouth's medium containing insulin (0.15 µM) as the only hormone. Cultures were maintained for 5 days at 37°C in 5% CO 2 atmosphere, with replacement of the medium every 48 h, commencing 3 h after plating. Hep G2 cells and HEK 293 cells were maintained in DMEM supplemented with 10% FBS. Routinely, infections with the adenovirus were performed 48 h after hepatocyte isolation, and expression of the transgene was induced by the addition of doxycycline at the day of infection and again 48 h later. The cells were treated with IL-1β 72 h after the infection. The inhibitors AG126 (25 mM stock solution in ethanol) and OA (0.5 mM stock solution in ethanol) were added to the cells 30 min before treatment with IL-1β. AG126 was used at a concentration of 25 or 50 µM, and OA was added at a final concentration of 10 nM. According to the manufacturer's directions, at this concentration, OA is specific for PP2A and is not effective toward PP1 (IC 50 =42 nM), PP2B (IC 50 =5000 nM), or PP2C (IC 50 >>10,000 nM). The control dishes were treated with the appropriate amount of ethanol as a vehicle control. Hep G2 and HEK 293 cells (75-90% confluent) were infected according to the same protocol. Cell viability was determined using trypan blue.
Preparation of cell extracts
Initially, the medium was removed and cells were washed twice with phosphate-buffered saline (PBS). For primary hepatocytes, the Matrigel was reliquidized by incubating the tissue culture dishes in PBS containing 5 mM EDTA for 30 min at 4°C. The Matrigel was removed by centrifugation at 500g for 4 min, and the cells were washed once again with PBS. HepG2 and HEK 293 cells were harvested using cell scrapers and pelleted by centrifugation. For NSMase-2 expression and activity assays, 3 × 10 6 cells were resuspended in 0.5 ml of PBS and lysed with three consecutive freeze-thaw cycles. For JNK phosphorylation studies, the cell pellet was resuspended in 200 µl lysis buffer consisting of 1 mM EDTA, 1% Triton X-100, 1 mM Na 2 VO 4 ,Cell lysates were treated with recombinant lambda PPase from bacteriophage origin. After lysis, 40 µg of cell protein was incubated with 600 U of PPase in a buffer containing 50 mM Tris-HCl (pH 7.5), 0.1 mM Na 2 EDTA, 5 mM dithiothreitol, and 0.01% Brij 35 and was supplemented with 2 mM MnCl 2 , pepstatin A, 10 µg/ml each of leupeptin and aprotinin, 0.5 mM PMSF, and 1 mM benzamidine. The final volume was 15 µl, and the reaction was done for 30 min at 30°C. Control reactions lacking the PPase were performed in parallel.
SDS-PAGE and Western blot analyses
The protein concentration in cell extract was measured by Lowry assay. Proteins (25 µg/lane) were resolved by 7.5% or 10% SDS-PAGE and transferred to Immobilon-p PVDI membrane by semidry blotting. The membranes were then blocked in PBS containing 0.5% Tween-20. The FLAG-tagged NSMase-2 was detected using anti-FLAG M2 monoclonal antibody (Sigma) at a dilution of 1:2000, followed by rabbit anti-mouse IgG alkaline phosphatase-conjugated secondary antibody at a dilution of 1:10,000. For analyses of JNK activation, the membranes were incubated for 4 h at room temperature with antibodies (dilution of 1:4000) specific for the dually phosphorylated, active form of JNK followed by goat anti-rabbit IgG-alkaline phosphatase-conjugated antibody at a dilution of 1:10,000. IRAK phosphorylation was judged by the appearance of a higher molecular band on Western blot using anti-IRAK antibody. Proteinantibody interactions were visualized using the ECF kit (Amersham, Piscataway, NJ) and Storm860 fluorescent scanning instrument (Molecular Dynamics, Sunnyvale, CA) with Image Quant 5.0 software. The scanning conditions were adjusted to pixel size of 200 µm and photomultiplier tube voltage of 800 V to ensure that the intensity of all scanned bands is within the linear range of the instrument. The band intensity was measured in a "volume quantitation" mode, and the background correction was made using a "local average" background correction method. The scanning conditions were kept uniform between the experiments, and the quantified intensity of β-actin bands, which were used as a control for uniform loading, was similar for all experiments.
After proving the assumption of equal variance across groups, differences were assessed using Student's t test. The test was used to compare data between two groups, typically, induced vs. control infected but noninduced cells. Values are expressed as mean ± SE.
Indirect immunofluorescence
Cells were cultured on coverslips to 50% confluency and infected with AdNSMase-2 as described above. After 48 h, cells were washed three times with PBS containing 0.5% MgCl 2 (PBS-MgCl 2 ) and fixed with 3% paraformaldehide for 30 min at room temperature. The coverslips were then washed with PBS-MgCl 2 , incubated for 5 min in 10 mM NH 4 Cl, and washed again with PBS-MgCl 2 . Cells were permeabilized using 0.2% Triton X-100 for 15 min on ice and washed again with PBS-MgCl 2 . After blocking for 1 h with 1% bovine serum albumin (BSA) in PBS-MgCl 2 (PBS-MgCl 2 -BSA), cells were incubated with anti-FLAG M2 monoclonal antibody in PBS-MgCl 2 -BSA at a dilution of 1:200 for 1 h at room temperature. After washing four times with PBS-MgCl 2 -BSA, cells were incubated with FITC-conjugated goat anti-mouse IgG (1:200 in PBS-MgCl 2 -BSA) for 1 h in the dark. The coverslips were washed five more times in PBS-MgCl 2 -BSA, and cell staining was observed using confocal microscopy.
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Measurement of ceramide mass in cells
The lipids were extracted by the method of Blight and Dyer (24), modified as described previously (25) , and analyzed by thin-layer chromatography on silica gel 60 plates (10×20 cm) using chloroform:methanol:triethylamine:2-propanol:0.25% potassium chloride (30:9:18:25:6 by vol) as the developing solvent. Long-chain ceramide (bovine brain) was used as an external standard. The corresponding regions of the plate were scraped and eluted from the silica with 1 ml of chloroform:methanol (1:1 by vol) followed by 1 ml of methanol. The combined eluates were dried in vacuo, and then 0.5-1.0 nmol of N-acetyl-C 20 -sphinganine were added to the unknown ceramide sample, and the ceramide mass was quantified by HPLC of the long-chain bases released after an acid hydrolysis in 0.5 M HCl in methanol at 65°C for 15 h. Free longchain bases were analyzed as described by Merrill et al. (26) .
Assay of NSMase activity
NSMase activity was determined as described previously (19) with the following modifications: Cells from 10 cm 2 plates were resuspended in 0.5 ml of PBS, aliquoted, and lysed with three consecutive freeze-thaw cycles. NBD-SM was added at a final concentration of 10 µM (from 10 mM stock solution in ethanol) to an assay buffer consisting of 6.6 mM MgCl 2 , 10 mM Tris-HCl, pH 7.4, and 0.1% Triton X-100. Then 23 µl of the assay/substrate mixture and 7 µl of the cell lysates (containing 10 µg of cell protein) were mixed and incubated at 37°C. The reaction was stopped by adding 0.250 ml of methanol, and the products were analyzed by HPLC as described below. Product formation was proportional to the amount of added protein for up to 0.01 mg per assay.
HPLC analysis was done on a reverse-phase column (Nova Pak, C18; Bio-Rad, Hercules, CA). The NBD-lipids were separated using methanol:water:phosphoric acid (850:150:0.150 by vol) as a mobile phase at a flow rate of 2 ml/min.
RESULTS
Molecular cloning and functional characterization of NSMase-2
BLAST search of the GenBank mouse EST database identified two sequences that were identical to the 3′ end of the published mouse NSMase-2 cDNA (GenBank #AJ250461) that were fulllength clones. The I.M.A.G.E consortium clone 2076661 (GenBank #AI747200) was used in the studies after confirming that it encodes the full-length NSMase-2 cDNA. NSMase-2 was PCR amplified, sequenced, FLAG-tagged at the C terminus, and cloned into the shuttle vector pAd.trac.teton as described in Materials and Methods. The resulting construct, pAd.trac.tetonNSMase-2, was used for the initial characterization of NSMase-2 in transfected HEK 293 cells. NSMase-2 appeared on a Western blot as a single band of apparent molecular weight of 73 kDa, which was slightly higher than the previously reported size of 71 kDa (13) . The difference could be due to the FLAG tag.
Protein expression was detectable at 16 h of induction and increased significantly by 48 h (Fig.  1A) . The induction of expression resulted in a significant increase in the initial velocity of NSMase activity, from ~1 pmol/min in the noninduced HEK 293 cells to 30 pmol/min in the induced cells. The activity increased with time in a linear fashion, reaching saturation at 10 min when up to 75% of the exogenous substrate was hydrolyzed. HPLC analyses confirmed that only one product, NBD-ceramide, was generated at the expected molar ratio of 1:1 (Fig. 1B) . The addition of 0.5% Triton X-100 or 50 mM EDTA to the assay mixture suppressed the NSMase activity to the level seen in noninduced cells (Fig. 1C) . Purification of the NSMase-2 protein using anti-FLAG-M2 affinity gel led to significant loss of activity (data not shown). Taken together, these results indicate that the cloned NSMase-2 gene encodes a functionally active Mg 2+ -dependent NSMase.
Expression of functional NSMase-2 in primary rat hepatocytes
After confirming the inducible expression of a functional SMase from the pAd.trac.tetonNSMase-2, we used the construct to generate recombinant adenovirus (AdNSMase-2) expressing NSMase-2 as described in Materials and Methods. AdNSMase-2 was used to infect primary hepatocytes, where, as in HEK 293 cells, induction of NSMase-2 expression led to the production of a 73 kDa protein. The expression was noticeable at 16 h of induction, reached a maximum at 48 h, and stayed relatively stable after that ( Fig. 2A) . Assays of NSMase activity in cell extracts indicated a more than 20 times greater activity in induced cells as compared with the control infected but noninduced cells. More importantly, overexpression of NSMase-2 resulted in increases in the levels of cellular ceramide by 30%, 62%, and 73% at 16, 48, and 72 h, respectively (Fig. 2B) . This corresponds to an increase by 0.5, 1.25, and 1.3 nmol/mg protein, respectively. This clearly indicates that the expressed NSMase-2 hydrolyzes endogenous substrate, resulting in increased generation of ceramide in the cells. The magnitude of these increases was smaller than that observed toward exogenous substrate. Such differences could be explained by 1) limited availability of accessible SM inside the cells, 2) degradation of ceramide to sphingosine by a ceramidase, and 3) conversion of ceramide generated in the cells back to SM (or other complex sphingolipids) by cellular SM synthase or glucosyl ceramide synthase. Note, however, that the magnitude of the observed ceramide increases in the cells is comparable to that seen in response to physiological inducers of SMase activity such as IL-1β and TNF-α (2).
In many cell types, accumulation of ceramide has been related to an increase in cell death. Therefore, following infection, cell viability was tested every 24 h using trypan blue exclusion assay. No statistically significant differences were found between control noninfected cells and cells infected with the adenovirus in the presence or absence of doxycycline (data not shown). This confirms earlier findings that differentiated primary hepatocytes are relatively resistant to ceramide-induced cell death (27) .
Subcellular localization of NSMase-2
The neutral sphingomyelinase has been suggested to be a plasma membrane-bound enzyme (4), and the predicted amino acid sequence for NSMase-2 reveals two putative transmembrane domains at the N-terminus (13) . However, when the subcellular localization of NSMase-2 was studied in PC-12 cells and in a human neuroblastoma cell line, it was found that NSMase-2 colocalized with markers for the Golgi apparatus (13) . Thus, it was of interest to determine the subcellular localization of NSMase-2 in hepatocytes. We used AdNSMase-2-infected Hep G2 cells, where the induction pattern, levels of expression, and activity of the expressed NSMase-2 were similar to those observed in primary hepatocytes (data not shown). The subcellular localization of the FLAG-tagged protein was determined by confocal microscopy using anti-FLAG antibody followed by FITC-conjugated secondary antibody. These experiments showed that NSMase-2 was localized to the plasma membrane (Fig. 3) . It is important to emphasize that in all studies, including those for NSMase-2 subcellular localization, the adenoviral MOI, doxycycline concentration, and the times of induction were carefully optimized in advance to ensure that the protein was not grossly overexpressed as judged by Western blot analyses.
Effects of NSMase-2 expression on IL-1β -induced JNK activation
Our previous studies have shown that IL-1β stimulates NSMase activity in primary hepatocytes (19) and, hence, it was of interest to see whether NSMase-2 has a role in IL-1β signaling. To this purpose, we first checked whether induction of NSMase-2 expression affects the ability of IL-1β to induce signaling by studying the activation pattern of JNK, one of the most important targets of IL-1β. Importantly, increased phosphorylation of JNK has been reported in response to increases in the intracellular ceramide content brought about by the exogenous addition of shortchain ceramide or bacterial SMase (28, 29) . As anticipated, treatment of hepatocytes with IL-1β increased the levels of the active, phosphorylated form of JNK. The effect was transient, decreasing after 15 min of treatment and receding to the basal level by 2 h (Fig. 4A, 4B ). NSMase-2 overexpression enhanced up to threefold the potential of IL-1β to induce JNK phosphorylation, whereas in the absence of IL-1β, NSMase-2 overexpression had only a small effect on JNK phosphorylation (Fig. 4A, 4B ).
To further characterize the relationship between NSMase-2 levels and IL-1β-induced JNK phosphorylation, we did a dose-response study (Fig. 4C, 4D) . The results confirmed that the magnitude of IL-1β-induced JNK phosphorylation was substantially increased in the presence of NSMase-2 over a broad range of IL-1β concentrations.
Inhibition of IRAK phosphorylation by AG126 does not influence the effects of NSMase-2 on JNK phosphorylation
The IL-1β IRAK-1 has a central role in the IL-1β signaling cascade. Upon IL-1β stimulation, IRAK-1 associates with the IL-1β receptor complex through the adaptor protein MyD88. It is then phosphorylated by IRAK-4 and other, yet unidentified, kinases. Subsequently, IRAK undergoes autophosphorylation and interacts with TNF-α receptor-associated factor (TRAF)-6. This triggers the release of the multiprotein signaling complex from the IL-1β receptor and the activation of transforming growth factor β-associated kinase (TAK)-1, ultimately leading to activation of the mitogen-activated protein (MAP) kinases and nuclear factor (NF)-κB (30) . In an effort to characterize the mechanism(s) by which NSMase-2 overexpression affects IL-1β signaling cascade, we used a putative tyrosine phosphorylation inhibitor, AG126. This inhibitor has been successfully used to prevent lipopolysaccharide (LPS)-induced IRAK activation (31) . Because the receptor for LPS and the IL-1β type I receptor share similar cytosolic tails (32) and activate IRAK-1 through similar mechanisms, we anticipated that AG126 would also inhibit IL-1β-induced IRAK phosphorylation. We monitored for IRAK phosphorylation using an antibody that recognizes both its phosphorylated and nonphosphorylated forms.
As can be seen on the Western blot shown in Figure 5A , IRAK appears as a single band of ~80 kDa in extracts from nontreated cells, whereas upon IL-1β treatment, multiple higher molecular weight bands are observed corresponding to the phosphorylated forms of IRAK. However, the addition of AG126 partially inhibited in a dose-dependent manner this IL-1β-induced phosphorylation of IRAK (Fig. 5A, right two lanes) . The observed decrease in IRAK phosphorylation was 50% at best, probably because AG126, a tyrosine kinase inhibitor, cannot block IRAK autophosphorylation that occurs at serine or threonine residues.
Next, we studied how AG126 affects the IL-1β-induced JNK phosphorylation in AdNSMase-2-infected primary rat hepatocytes (Fig. 5B, 5C ). When NSMase-2 expression was not induced, the addition of AG126 prevented IL-1β-induced JNK phosphorylation in a dose-dependent manner, with complete inhibition of phosphorylation seen at 50 µM AG126. In contrast, AG126 had only a partial effect in doxycycline-induced cells not being able to overcome the "potentiation" effect of NSMase-2 on IL-1β-induced JNK phosphorylation. The inhibitor alone had no detectable effect on the basal JNK phosphorylation (data not shown).
Taken together, these results exclude the possibility that NSMase-2 expression affects the IL-1β signaling cascade in a nonspecific manner, for example, by modulating the number of surface receptors or the process of ligand-induced receptor dimerization.
NSMase-2 overexpression affects the phosphorylation pattern of IRAK
One explanation for the above observations is that NSMase-2 does not affect the ability of IL-1β to phosphorylate IRAK but exerts its synergistic effect(s) on other, downstream, steps in the IL-1β signaling cascade. At the same time, however, it is still possible that NSMase-2 can induce or inhibit the phosphorylation of IRAK at residues that are not affected by AG126. It is known that hyperphosphorylation of IRAK-1 plays a dual role in IL-1β signaling. It triggers the release of IRAK-1 from the receptor complex, leading to binding and activation of TAK-1. At the same time, however, phosphorylated amino acids act as targets for IRAK ubiquitination and degradation that shut down the signaling pathway (30) . Therefore, we tested the effects of NSMase-2 overexpression on IL-1β-induced IRAK phosphorylation by Western blot analyses, as described in the previous paragraph. As expected, IL-1β induced IRAK phosphorylation as early as 8 min following treatment. This effect, however, was significantly suppressed when NSMase-2 was overexpressed (Fig. 6A ).
To verify that these observations indeed signified changes in IRAK phosphorylation, we treated cell lysates with bacteriophage PPase (Fig. 6B) . In the absence of NSMase-2 overexpression, this treatment significantly reduced the appearance of high molecular weight forms of IRAK and increased the intensity of the nonphosphorylated form of IRAK. As anticipated, the PPase treatment did not have a detectable effect in lysates from NSMase-2-overexpressing cells. This is consistent with the conclusion that the high molecular weight bands were phosphorylated forms of IRAK and that in the presence of NSMase-2 overexpression, IRAK was in a nonphosphorylated or less-phosphorylated state. These results suggested that NSMase-2 overexpression might inhibit a serine-threonine kinase or activate a protein phosphatase.
NSMase-2 potentiates IL-1β-induced JNK activation in a PP2A-dependent manner
Among the most well characterized ceramide targets is ceramide-activated protein phosphatase (CAPP), which is activated in response to ceramide accumulation (33, 34) . The activation of CAPP has been shown to mediate the ability of ceramide to induce cell growth arrest by downregulating c-myc (34) . CAPP is a member of the PP2A family of protein phosphatases that can be selectively inhibited by 10 nM OA (34) . Therefore, we decided to test whether OA treatment will affect the ability of NSMase-2 to enhance IL-1β-induced JNK activation. As can be seen in Figures 6C and 6D , OA completely abolished the potentiative effect of NSMase-2, indicating that the ability of NSMase-2 to augment IL-1β-induced JNK activation is indeed mediated by activation of a member of the PP2A family, possibly CAPP.
DISCUSSION
This study provides evidence that NSMase-2, an enzyme cloned by sequence homology analyses and proposed to be the mammalian neutral SMase, can modulate cell signaling and, more specifically, IL-1β-induced JNK activation. We also present data indicating that in hepatocytes, the enzyme is localized to the plasma membrane and can regulate intracellular ceramide content.
Enzymatic analyses of the cloned NSMase-2 confirmed the NSMase nature of the enzyme and its Mg 2+ dependency. This is in agreement with a recently published biochemical characterization of NSMase-2 (17) . Interestingly, when measured in vitro using NBD-SM as a substrate, NSMase-2 activity was inhibited in the presence of 0.5% Triton X-100. This would explain the substantial loss of activity upon purification of the enzyme observed in this study. Similar loss of activity was reported for the purified NSMase-1, which has a catalytic domain homologous to that of NSMase-2 (15). The loss of activity is apparently due to delipidation of the enzyme, because it has not been observed when 3.3 mol % of phosphatidylserine is used as a cofactor in the NSMase-2 activity assays (17) . Taken together, these results suggest that 1) NSMase-2 has to be membrane-bound in order to maintain its active configuration or that 2) its substrate has to be embedded into a membrane bilayer for appropriate delivery.
Experimental data accumulated over the past decade have shown that the subcellular site of ceramide generation is an important determinant for its ability to mediate cell signaling (35) . Numerous studies have suggested that bioactive ceramide is mainly synthesized at the plasma membrane; however, until now, neither of the two putatitive NSMases had been localized to the plasma membrane. The only published study on the subcellular localization of NSMase-2 reported that in PC-12 cells, the enzyme has Golgi localization (13). In contrast, our studies find that in hepatocytes, NSMase-2 is localized at the plasma membrane. These differences could be due to 1) differences rising from the different cell types or 2) the fact that our studies use antibody against the FLAG-tagged NSMase-2, whereas the aforementioned study uses antibody against the endogenous enzyme.
Our finding offers a new insight into the possible cellular functions of NSMase-2. First and foremost, the enzyme is in close proximity to key components of the IL-1β signaling cascade, such as IL-1β receptors, IRAK, and TAK-1. Second, bearing in mind that no ceramide-transfer proteins have been discovered so far and that the spontaneous transfer of ceramide among lipid bilayers is very inefficient (36) , it is likely that NSMase-2-generated ceramide remains at the plasma membrane. Such localization of ceramide would prevent its conversion back to SM or to other complex sphingolipids, because, in contrast to the Golgi apparatus, plasma membranes have only a modest capacity to synthesize SM and no capacity to synthesize glycosphingolipids (37) . Therefore, NSMase-2-generated ceramide is likely to accumulate more efficiently in response to different agonists.
Interestingly, the main pathway to clear ceramide from the plasma membrane is through its turnover, which is catalyzed by a neutral plasma membrane-associated ceramidase (38) that apparently is regulated by IL-1β (19) . Furthermore, recent studies have shown that the cytosolic sphingosine kinase can be translocated to the plasma membrane (39) and could thus convert sphingosine to sphingosine phosphate, which is another potent pro-inflammatory second messenger (19, 40) . All this raises the intriguing possibility that NSMase-2 is the first enzyme in the proposed IL-1β-regulated sphingolipid signaling cascade of the plasma membrane.
IL-1β is a pleotropic cytokine that mediates numerous inflammatory responses in hepatocytes during the acute-phase response to infection. These responses are initiated by ligand-induced dimerization of the IL-1 receptor type I and the IL-1 receptor accessory protein, followed by recruitment of IRAK to the complex that also includes the cytosolic myeloid differentiation protein MyD88 and, possibly, TRAF-6. The receptor-bound IRAK is phosphorylated at multiple residues, which initiates the disassociation of the complex from the receptor and ultimately leads to activation of TAK-1. The activated TAK-1 then acts on either the MAP kinase cascade to induce JNK or the NIK-IKK cascade to activate NF-κB (41) .
Increases in the endogenous ceramide levels by the addition of exogenous ceramide analogs or by treatment of cells with bacterial sphingomyelinase have been shown in different cell types to mimic the IL-1β-induced activation of JNK. Furthermore, biochemical studies have correlated activation of a neutral SMase with the activation of JNK (42, 43, 44) . Direct evidence for the role of NSMase and the identity of the gene encoding it, however, has been lacking. Therefore, our findings that overexpression of NSMase-2 potentiates the ability of IL-β to activate JNK provide the first evidence for NSMase-2 involvement in the regulation of JNK.
The mechanism by which NSMase-2 enhances the IL-1β-induced activation of JNK is not completely clear. The experiments in this manuscript provide compelling evidence that a phosphatase from the PP2A family mediates the NSMase-2 effects on JNK, possibly by modulating the phosphorylation pattern of IRAK. The fact that AG126 did not inhibit NSMase-2 effects indicates that NSMase-2 overexpression does not influence IRAK phosphorylation at tyrosine residues. Apparently, however, NSMase-2 keeps IRAK in a less-phosphorylated form by activating protein phosphatase from the PP2A family. At this point, we cannot determine whether the phosphatase affects the phosphorylation of IRAK-1 while the kinase is attached to the receptor or when it is in the cytosol in a complex with TRAF-6 and TAK-1. The latter possibility, however, appears to better fit the observed potentiation of the downstream signaling in the presence of NSMase-2 (Fig. 7) .
The mechanism by which dephosphorylation of the hyperphosphorylated IRAK-1 leads to potentiation of JNK activation is currently unclear. It is known that the phosphorylated amino acids in IRAK act as targets for ubiquitin ligase. IRAK's ubiquitination leads to its degradation and shuts down the signaling pathway (30) . It is therefore conceivable that dephosphorylation would prevent IRAK degradation, resulting in enhanced downstream signaling. Alternatively, because only the nonphosphorylated IRAK interacts with MyD88, dephosphorylation may increase IRAK's affinity for MyD88 and thus may anchor the kinase back to the receptor, leading to a more sustained activation of the cascade. Our ongoing studies are aimed at testing these different possibilities.
In summary, the results presented here provide insight on the cellular functions of the recently cloned NSMase-2. Specifically, they show that in hepatocytes, NSMase-2 is localized at the plasma membrane, where it can regulate intracellular levels of ceramide, and plays a role in the IL-1β signal transduction pathway. A, C) AdNSMase-2 infected primary rat hepatocytes were cultured in the presence or absence of doxycycline (2 µg/ml) for 72 h. The cells were then treated with 25 ng/ml of IL-1β for the indicated times (A) or with the indicated doses for 15 min (C). Cells were harvested and lysed, and the phosphorylation of JNK was determined by Western blot using an antibody specific for the dually phosphorylated active form of JNK. B, D) Quantification of the intensity of the pJNK bands from A and C was done using Storm860 scanning instrument as described in Materials and Methods. Values represent combined intensity of JNK1 and JNK2. Data are mean ± SE. B) n=4 replicates from three different hepatocyte preparations. D) n=3 replicates from two different hepatocyte preparations. **P ≤ 0.01, *P ≤ 0.05 for comparison between induced and noninduced cells. β-Actin was used as a control for uniform loading. AG126 inhibits IL-1β-induced IRAK phosphorylation. Primary hepatocytes were pretreated with either AG126 or vehicle control (0.2% ethanol) for 30 min, and then IL-1β (25 ng/ml) was added as indicated. After 15 min, cells were harvested, lysed, and analyzed for IRAK on a Western blot of a 7.5% SDS-PAGE using polyclonal antibody specific for IRAK-1. B) Primary rat hepatocytes were infected with AdNSMase-2, induced and noninduced, for 72 h and treated for 30 min with AG126 or vehicle control (0.2% ethanol) as indicated. IL-1β (25 ng/ml) was then added for 15 min, and cells were harvested, lysed, and analyzed for phosphorylation of JNK as described in Figure 4 . C) Quantification of the intensity of pJNK bands from B performed using Storm860 scanning instrument. The data are mean ± SE, n=2 replicates from two different hepatocyte preparations. *P < 0.05 for comparison between induced, IL-1β-treated cells in the absence and presence of AG126. AdNSMase-2-infected primary rat hepatocytes were cultured in the presence or absence of doxycycline (2 µg/ml) for 72 h. The cells were then treated with 25 ng/ml of IL-1β for the indicated times. A) Cells were lysed and analyzed for IRAK phosphorylation as described in Figure 5 . B) After lysis, 40 µg of cell protein was incubated with 600 U of recombinant lambda protein phosphatase (PPase) from bacteriophage origin for 30 min at 30 o C. Control reactions lacking the PPase were performed in parallel. The assay mixtures were loaded on 7.5% gel and analyzed for IRAK phosphorylation as described in Figure 5 . C) Primary hepatocytes were incubated with 10 nM okadaic acid (OA) for 30 min before and during the treatment with IL-1β (25 ng/ml, for 15 min). After that, the hepatocytes were harvested, lysed, and analyzed for phosphorylation of JNK as described in Figure 4 . D) Quantification of the intensity of the pJNK bands from C was done using a Storm860 scanning instrument as described in Materials and Methods. Values represent combined intensity of JNK1 and JNK2. Data are mean ± SE, n=3 replicates from two different hepatocyte preparations.
# P ≤0.05 for comparison between induced, IL-1β-treated cells in the absence and presence of OA. dimerization of the IL-1 receptor type I and the IL-1 receptor accessory protein, following which IRAK is recruited to the complex that also includes the cytosolic myeloid differentiation protein MyD88 and TNF receptor-associated factor 6 (TRAF 6). The receptor-bound IRAK becomes highly phosphorylated, which initiates the dissociation of the multiprotein complex from the receptor. TAK-1 is then recruited to the complex and activates either the MAP kinase cascade to induce JNK or the NIK-IKK cascade to activate NFkB. The signaling cascade is shut down by ubiquitination and degradation of hyperphosphorylated IRAK. The putative Mg 2+ -dependent neutral SMase, NSMase-2, is localized at the plasma membrane, generates excess ceramide, and activates a serine threonine phosphatase from the PP2A family. This keeps IRAK in a less phosphorylated form and potentiates the activation of JNK by a mechanism that is not yet fully understood.
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